In this meta-analysis of randomized controlled trials involving participants with nonalcoholic fatty liver disease, supplementation with probiotics, prebiotics, or synbiotics reduced fasting insulin to a small degree but had no effect on other biomarkers of glycemic control.
This Study Summary was published on November 27, 2024.
